|
.
NPI Detail
NPI: 1033154026
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
3188 XXXXXXXX XXXXXX
CINCINNATI, OH 452199998
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1033154026*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
Procedure | Description | Number Submitted | Medicare Payment |
36415
|
ROUTINE VENIPUNCTURE
|
XXXXX
|
$XXXXX.XX
|
80053
|
COMPREHEN METABOLIC PANEL
|
XXXXX
|
$XXXXXX.XX
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
Procedure | Description | Number Submitted | Medicare Payment |
J7192
|
Factor viii recombinant nos
|
XXXXXXX
|
$XXXXXXX.XX
|
J7207
|
Factor viii pegylated recomb
|
XXXXXX
|
$XXXXXX.XX
|
J1642
|
Inj heparin sodium per 10 u
|
XXXXXX
|
-
|
J0485
|
Belatacept injection
|
XXXXXX
|
$XXXXXX.XX
|
J3490
|
Drugs unclassified injection
|
XXXXX
|
-
|
J2704
|
Inj, propofol, 10 mg
|
XXXXX
|
-
|
J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
J7328
|
Gelsyn-3 injection 0.1 mg
|
XXXXX
|
$XXXXXX.XX
|
J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
J0585
|
Injection,onabotulinumtoxina
|
XXXXX
|
$XXXXXX.XX
|
J2350
|
Injection, ocrelizumab, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
J0185
|
Inj., aprepitant, 1 mg
|
XXXXX
|
$XXXXX.XX
|
J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
J1569
|
Gammagard liquid injection
|
XXXXX
|
$XXXXXX.XX
|
J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
J2795
|
Ropivacaine hcl injection
|
XXXXX
|
-
|
J7187
|
Humate-p, inj
|
XXXXX
|
$XXXXX.XX
|
J9263
|
Oxaliplatin
|
XXXXX
|
-
|
J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
J0881
|
Darbepoetin alfa, non-esrd
|
XXXXX
|
$XXXXX.XX
|
J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
J0461
|
Atropine sulfate injection
|
XXXXX
|
-
|
J0131
|
Inj, acetaminophen (nos)
|
XXXXX
|
-
|
J1442
|
Inj filgrastim excl biosimil
|
XXXXX
|
$XXXX.XX
|
J0588
|
Incobotulinumtoxin a
|
XXXXX
|
$XXXXX.XX
|
J2323
|
Natalizumab injection
|
XXXXX
|
$XXXXXX.XX
|
J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
Top HCPC Level II Procedures / Professional Services
Procedure | Description | Number Submitted | Medicare Payment |
G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
G0378
|
Hospital observation per hr
|
XXXXX
|
-
|
U0003
|
Cov-19 amp prb hgh thruput
|
XXXXX
|
$XXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|